RAPID Reserve Act

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 3955 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 3955 To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 12, 2025 Ms. Craig (for herself and Mr. Van Drew) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Rolling Active Pharmaceutical Ingredient and Drug Reserve Act'' or the ``RAPID Reserve Act''. SEC. 2. ROLLING ACTIVE PHARMACEUTICAL INGREDIENT AND DRUG RESERVE. (a) In General.--The Secretary of Health and Human Services (referred to in this section as the ``Secretary'') shall award contracts or cooperative agreements to eligible entities with respect to drugs and active pharmaceutical ingredients of such drugs that the Secretary determines to be critical and to have vulnerable supply chains. The Secretary shall publish the list of such drugs and active pharmaceutical ingredients of such drugs. (b) Requirements.-- (1) In general.--An eligible entity, pursuant to a contract or cooperative agreement under subsection (a), shall agree to-- (A) maintain, in a satisfactory domest